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Abstract 
Background: In acute kidney injury (AKI), useless continuation of renal replacement therapy (RRT) may delay renal 
recovery and impair patient’s outcome. In this study, we aimed to identify predictive parameters that may help to a 
successful RRT weaning for AKI patients.
Methods: We studied 54 surviving AKI patients in which a weaning of RRT was attempted. On the day of weaning 
(D0) and the following 2 days (D1 and D2), SAPS II and SOFA scores, 24-h diuresis, 24-h urinary creatinine and urea 
(UCr and UUr), creatinine and urea generation rates (CrGR and UrGR) and clearances (CrCl and UrCl) were collected. 
Patients who remained free of RRT 15 days after its discontinuation were considered as successfully weaned.
Results: Twenty-six RRT weaning attempts succeeded (S+) and 28 failed (S−). Age, previous renal function, SAPS 
II and SOFA scores were comparable between groups. At D0, 24-h diuresis was 2300 versus 1950 ml in S+ and S−, 
respectively, p = 0.05. At D0, D1 and D2, 24-h UUr and UCr levels, UrCl and CrCl, and UUr/UrGR and UCr/CrGR ratios 
were significantly higher in S+ group. By multivariate analysis, D1 24-h UCr was the most powerful parameter that was 
associated with RRT weaning success with an area under the ROC curve of 0.86 [0.75–0.97] and an odds ratio of 2.01 
[1.27–3.18], p = 0.003.
Conclusions: In ICU AKI, 24-h UCr appeared as an efficient and independent marker of a successful weaning of RRT. 
A 24-h UCr ≥5.2 mmol was associated with a successful weaning in 84 % of patients.
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Background
Acute kidney injury (AKI) is a common condition in the 
intensive care unit (ICU). Approximately 5  % of ICU 
patients suffering from AKI require renal replacement 
therapy (RRT) [1]. Such patients have a hospital mortality 
rate of 45–70 % [1–6], and those surviving to hospital dis-
charge continue to carry a high risk for long-term mor-
bidity and mortality [7–10]. Several studies have shown 
that between 10 and 30  % of patients with AKI who 
required RRT will remain dialysis dependent at discharge 
[7–13]. Yet, renal function in AKI surviving patients 
requiring RRT ultimately recovers in the vast majority 
of case (more than 90 % of patients) [14]. However, per-
formances of RRT may have untoward effects that con-
tribute to the prolongation of renal failure or impede the 
ultimate recovery of renal function [15]. Indeed, RRT 
represents an independent and an added risk factor for 
mortality [16–18] as it exposes the patient to several 
complications like catheter-related infections or throm-
bosis, bleeding favored by anticoagulation, hemodynamic 
instability. The prolonged continuation of RRT could 
also be deleterious for renal recovery, particularly in 
cases of intradialytic hemodynamic instability, inducing 
renal ischemic lesions [19]. Renal biopsy in patients with 
prolonged AKI treated by hemodialysis showed regions 
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of fresh tubular necrosis days-to-weeks after the initial 
insult [20]. RRT may also delay renal recovery possibly 
by purification of mediators and growth factors needful 
for the tubular repair [21]. Moreover, RRT may remove 
unpredictable amounts of antibiotics, amino acids and 
nutrients. Also, RRT represents a significant additional 
cost in the patient’s care. It is therefore a matter of con-
cern to identify which factors present at the time of dis-
continuation may help physicians in predicting successful 
cessation of RRT [22]. To the best of our knowledge, a 
paucity of studies has been reported on RRT weaning 
during AKI [23–26]. Sepsis-related Organ Failure Assess-
ment (SOFA) score [23, 26] and 2-h creatinine clearance 
[25] have been reported as a reliable predictive factors, 
but urine output remains the most consistent parameter 
significantly associated with the success of weaning [24]. 
This study was therefore undertaken to investigate and 
identify parameters, particularly 24-h urinary creatinine, 
present at the time of RRT weaning that would be associ-
ated with successful cessation of RRT during AKI.
Patients and methods
This retrospective study was conducted, from Janu-
ary 2008 to December 2012, in two medical ICUs of the 
Montpellier University Hospital, France. It was approved 
by our local institutional review board (Ethic Committee 
of Montpellier; Comité de protection des personnes: CPP 
Sud Mediterranée 4) which waived informed consent 
from the patients or their relatives.
Study population
Patients admitted to the ICU for AKI requiring RRT 
that survived and in which an attempt of weaning was 
realized were enrolled in the study. Exclusion criteria 
included pregnancy, age <18 years old, previous chronic 
renal failure stage ≥4, AKI of obstructive, glomerular 
or vascular etiology. AKI patients that underwent acute 
RRT for less than 3  days (no attempt of weaning), and 
patients without an attempt of weaning RRT or trans-
ferred to another unit before an attempt of weaning were 
also excluded. Decisions regarding the initiation, man-
agement and discontinuation of RRT were made by the 
referring physician according to the guidelines of the 
intensive care and nephrology societies [22]. The choice 
of RRT modality was depending on patient hemody-
namic stability and was daily re-evaluated. Patients with 
hemodynamic instability or severe fluid overload were 
preferentially treated with pre-dilutional continuous 
venovenous hemodiafiltration (CVVHDF) or on-line 
sustained low-efficiency daily dialysis-filtration (SLEDD-
f ), and those with hemodynamic stability were preferen-
tially treated with on-line intermittent hemodiafiltration 
(IHDF) [27].
Study design
An RRT cessation was considered as an attempt of wean-
ing when referred to a medical decision and if it lasted 
more than 72  h. Only the first attempt was analyzed 
for each patient. Current criteria required for weaning 
attempt were the association of an urine output of at least 
20 ml/h without diuretics [24, 28], a restored and stable 
hemodynamic and respiratory conditions, no new kid-
ney aggression (mainly toxic and predictable), no need 
to continue RRT for the previously mentioned reasons. A 
successful weaning was defined as the cessation of RRT 
for at least 15 days. This endpoint defined two groups of 
patients: S+ for the success of the weaning attempt and 
S− if it failed.
Data collection
Baseline patient characteristics were recorded, including 
age, gender, cause of AKI, comorbidities, previous renal 
function (estimation of glomerular filtration rate—eGFR, 
by the Chronic Kidney Disease Epidemiology, CKD-epi 
formula [29]), weight, urine volume. Severity of illness 
was determined at the inclusion using the simplified 
acute physiology score II (SAPS II) and the Sequential 
Organ Failure Assessment (SOFA) score. RRT modalities 
were collected during treatment.
Day 0 (D0) was defined as the day of RRT cessation at 
the weaning attempt, and D1, D2 the 2 following days. 
From D0 to D2, we daily collected the following param-
eters: non-renal SOFA score, patient’s weight, 24-h urine 
output, dose of furosemide, fluid balance (intake out-
put), mean arterial pressure, dose of vasopressors, use 
of mechanical ventilation, creatinine and urea blood and 
urine levels. Blood samples were drawn and 24-h urine 
samples were collected at D0 and every following day. 
Creatinine and urea clearance (CrCl and UrCl), diuretic 
response index and creatinine and urea generation rate 
(CrGR and UrGR, respectively) were estimated at D1 and 
D2 according to:
  • Diuretic response index (ml/mg) =  24-h urine out-
put (ml)/daily dose of furosemide (mg)
  • CrGR D1 (µmol/mn) = [(SCrD1 − SCrD0) × 0.6 × w
eight) + (UCr × urine volume)]/time D0 − D1
  • UrGR D1 (µmol/mn) = [(SUr D1 − SUr D0) × 0.6 × 
weight) + (UUr × urine volume)]/time D0 − D1
  • CrCl (ml/mn)  =  (UCr  ×  24-h urine volume)/
(Scr × 1440)
  • UrCl (ml/mn)  =  (UUr  ×  24-h urine volume)/
(Sur × 1440)
where SCr: serum creatinine (µmol/l), UCr: urinary cre-
atinine (mmol/l), SUr: serum urea (mmol/l), UUr: urinary 
urea (mmol/l), weight (kg), urine volume (l), time (min).
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Early re-renal replacement therapy, defined as relapsed 
need for RRT within 15 days after D0 was considered as 
the primary outcome variable. Duration of mechanical 
ventilation, vasopressor treatment and RRT, hospital and 
3-month mortality, and the need of RRT after 3 months 
were also collected.
Statistical analyses
Statistical analyses were performed using the software R 
3.1.0 (R Foundation for Statistical Computing, Vienna, 
Austria). We first performed a descriptive analysis by 
computing the frequencies and the percents for catego-
rial data; means or medians, standard deviations, quartiles 
and extreme values for continuous data. We also checked 
for the normality of the continuous data distribution using 
the Shapiro–Wilk tests. The univariate analysis was per-
formed using two-tailed Student’s t test for continuous 
variables, Fisher and Chi-square tests for categorial vari-
ables or two-tailed Mann–Whitney–Wilcoxon test when 
appropriate. The areas under the receiver operator char-
acteristic (ROC) curves and their confidence interval (CI) 
were calculated using the method of DeLong. The optimal 
threshold value was set for each ROC curve through the 
Youden index (corresponding to the maximum of the sum 
sensitivity + specificity). CIs for sensitivity (Se), specificity 
(Sp), positive predictive value (PPV) and negative predic-
tive value (NPV) were calculated by bootstrap (2000 boot-
strap samples). The most relevant variables including urine 
output, serum creatinine, creatinine clearance, urea and 
creatinine generation rate and 24-h urinary urea and creati-
nine obtained by logistic regression were included in multi-
variate models. The urea and creatinine kinetics in the two 
groups of patients were modeled using mixed models. A p 
value less than 0.05 was considered statistically significant.
Results
Population
During the study period, 377 consecutive patients were 
admitted in ICUs with AKI treated by RRT in which 179 
survived (survival rate 47.4  %). After exclusion of 125 
patients, 54 were eligible for analysis: 18 females and 36 
males (flowchart, Fig.  1). Patient’s characteristics, main 
comorbidities and reasons of ICU admission are summa-
rized in Table 1. The RRT modalities were equally repre-
sented in the study population. At DO, non-renal SOFA 
score has decreased reaching a median value of 3, and 
more than half of population was still on mechanical ven-
tilation (Table  2). Median duration of RRT prior to the 
first attempt of weaning was 11 days.  
Factors related to the success of weaning of RRT
Among the 54 patients, 26 attempts of weaning suc-
ceeded (S+ group) while 28 failed (S− group). Baseline 
characteristics of the two groups were comparable 
(Table 1). The proportion of CVVHDF was more impor-
tant in S+ group (50 vs 21 %) and conversely for IHDF, but 
differences were not statistically significant (p  =  0.07). 
At the day of RRT cessation, the proportion of patients 
mechanically ventilated was similar between groups as 
were non-renal SOFA score and prior duration of RRT. 
Clinical parameters including mean arterial pressure, 
dose of vasopressors, mechanical ventilation and fluid 
balance did not differ between the two groups. However, 
a higher weight decrease was observed in the success 
group but without significant differences (Table 2).
At D0, D1 and D2 urea and creatinine blood levels did 
not differ between the two groups (Table 3). At D0, 24-h 
urine output tended to be higher in S+ group (2300 vs 
1950 ml, p = 0.052) but most of patients were treated by 
diuretics in both groups (73 vs 86 %). Diuretic response 
index was significantly higher in the S+ group at D0 with 
a significant decrease in furosemide dose the following 
two days as compared to S− (Table 3). UrCl, CrCl, UUr 
and UCr levels were significantly higher in group S+ at 
D0, D1 and D2. UUr/UrGR and UCr/CrGR ratios were 
also significantly higher in S+ group (Table 3). By multi-
variate analysis, 24-h UCr was the most powerful vari-
able to predict the success of RRT weaning. At D0, its 
area under the ROC curve (AUC and 95 % CI) was 0.76 
[0.62–0.89] as compared to that of 24-h urine output: 
0.66 [0.51–0.80] (Fig. 2). AUC of 24-h urinary creatinine 
was 0.86 [0.75–0.97] and 0.86 [0.75–0.97] at D1 and D2, 
respectively (Fig.  2). D1 24-h creatininuria was a strong 
predictor of successful weaning with an odds ratio at 2.01 
[1.27–3.18], p = 0.003, independently of age, weight and 
diuresis and showed Se, Sp, NPV and PPV at 75, 88, 82 
and 84  %, respectively, when ≥5.2  mmol/24  h [3.1–6.3] 
(Table 4).
Patients’ outcome
A significantly shorter ICU length of stay (13.5 vs 
24.5 days) and a shorter duration of RRT (10.5 vs 18 days) 
were observed in the S+ group (Table  1). Patients from 
the S− group had resumed RRT 4 (3–11) days after the 
attempt of weaning. Twenty-one of the 28 patients of 
this group were weaned of RRT after a second attempt, 
whereas 7 needed more than two attempts (only one 
patient was re-dialyzed after the seventh day). Hospital 
survival was at 100 % in both groups, but 3 months later, 
4 patients deceased in the S− group and none in the S+ 
group.
Discussion
In this study, we found that almost half of surviving AKI 
patients treated with RRT had their treatment stopped 
at the first attempt. We found also that the capability of 
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24-h urine output to predict RRT weaning was signifi-
cantly altered by the use of diuretics. In contrast, 24-h 
urinary creatinine appeared as a powerful marker of suc-
cessful discontinuation of RRT even if patients received 
diuretics.
A large majority of ICU patients with AKI may recover 
sufficient kidney function to be independent of RRT. 
Indeed, all surviving patients we investigated herein 
recovered and were weaned from RRT even if several 
weaning attempts were necessary in some of them. Cur-
rently, practices of RRT weaning during AKI depend on 
every center policy and vary from a “wait and see” and a 
“go fast” attitudes. The “wait and see” attitude may pro-
long needlessly RRT and expose the patient to its haz-
ardous effects without any benefits. Conversely a “go 
fast” attitude may lead to several unsuccessful attempts 
of weaning with the subsequent requirement of re-insti-
tution that is by itself harmful. Appropriate cessation 
of RRT is obviously critical regarding clinical and eco-
nomic outcomes. There is, however, a paucity of data 
about how and when to stop RRT in critically ill patients 
with AKI, and identification of predictive factors of suc-
cessful cessation of RRT is scarce. This lack of evidence 
contrasts with the field of mechanical ventilation, where 
many studies dealing with the process of weaning have 
been conducted [30]. We sought therefore to evaluate, in 
the present study, whether cessation of RRT can be early 
determined on the basis of clinical and routinely used 
parameters.
Previous studies have reported the association of the 
success of an interruption of RRT with age [23], previ-
ous renal function [24, 25], the prior length of RRT, the 
SOFA score at ICU admission [23, 26] and its decrease 
from admission to the day of attempt [23]. None of these 
parameters have been found determinant in the suc-
cess of weaning in our study. Blood parameters includ-
ing serum urea and creatinine and their kinetic were also 
helpless to guide the weaning of RRT in our population. 
Urine output was reported to be the most important 
predictor of successful discontinuation of RRT. In the 
trial by Bouman et al. [31], continuous RRT was discon-
tinued when the urine output returned to and was sta-
ble at more than 60 ml/h, but there were no data about 
the optimal rate of urine output predicting the success 
of weaning. Wu et  al. [23] evaluated retrospectively 94 
patients weaned from IHDF for 5 or more days, of which 
64 were free from RRT for ≥30 days. 24-h diuresis was at 
1435 ± 1172 versus 598 ± 700 ml in the success and the 
re-dialysis groups, respectively, but diuretics were used in 
36 % of patients of both groups. Oliguria (100 ml in 8 h) 
was independently associated with re-initiation of RRT 
[23]. The BEST Kidney investigators [24] found that urine 
438 paents admied in ICU treated 
by RRT
28 failed aempts of weaning
(S- group)
377 paents with AKI
61 paents with CKD stage ≥ 4
179 surviving paents 
198 paents died  (52.5 %)
165 paents
14 paents with AKI secondary to urinary tract 
obstrucon, 
glomerulopathy or vascular disease
88 paents
77 paents treated by RRT < 72h
34 paents 
13 without an aempt of weaning 
15 with missing or unusable data
6 transferred to another unit
26 successful aempts of weaning
(S+ group)
54 paents analyzed
Fig. 1 Flowchart of the study population
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output of >400  ml/day without diuretics had the best 
operative characteristics with a Se, Sp, PPV and NPV of 
0.47, 0.81, 0.81 and 0.77, respectively. However, diuretics 
administration negatively affected its predictive ability. 
They concluded that patients with more than 400 ml/day 
of urine without diuretics or more than 2300 ml/day with 
diuretics have more than 80 % of chance to successful dis-
continuation of RRT. Recently, an urine output >8.5 ml/
kg/24 h was also found to predict IHDF weaning [32]. In 
our study, at the day of attempt, 24-h urine output failed 
to predict the success of weaning (2300 vs 1900 ml/24 h, 
p =  0.052) but a high proportion of our patients, more 
Table 1 Patients characteristics, comorbidities, causes of ICU admission, RRT modalities at initiation of therapy and out-
come according to the success or failure of RRT weaning attempt
Italic values indicate significance of p value (p <0.05)
Results are displayed in median [interquartile range] if quantitative variable; and number and percentage if categorial variable
p: differences between S+ and S− groups
SAPS II Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment, eGFR estimated glomerular filtration rate, IHDF intermittent hemodiafiltration, 
CVVHDF continuous venovenous hemodiafiltration, SLEDD-f sustained low-efficiency daily dialysis-filtration, RRT renal replacement therapy
All patients (n = 54) S+ group (n = 26) S− group (n = 28) p
Age (years) 63.5 [56–72.8] 61.5 [56–71] 67.5 [56.5–75.5] 0.12
Male [n (%)] 36 (67) 20 (77) 16 (51) 0.09
SAPS II 55 [39–69] 54 [39.5–65.8] 56 [40.5–74.5] 0.36
SOFA 11 [8–13] 11 [8.3–13] 11 [8.5–13] 0.51
Previous eGFR (ml/min/1.73 m2) 70 [45–92] 77 [45–96] 65 [46–89] 0.46
Main comorbidities [n (%)]
 Hypertension 28 (52) 12 (46) 16 (57) 0.16
 Diabetes 19 (35) 8 (31) 11 (39)
 Cardiac failure 8 (15) 4 (15) 4 (14)
 Hemopathy 8 (15) 2 (8) 6 (21)
Main reason for ICU admission [n (%)]
 Septic shock 28 (52) 11 (42) 17 (61) 0.15
 Cardiogenic shock/cardiac arrest 10 (19) 5 (19) 5 (18)
 Post-surgical 6 (13) 3 (12) 3 (11)
 Other 10 (13) 5 (19) 5 (18)
Initial RRT technique [n (%)]
 IHDF 19 (35) 6 (23) 13 (46) 0.07
 CVVHDF 19 (35) 13 (50) 6 (21)
 SLEDD-f 16 (30) 7 (27) 9 (32)
Length of ICU stay (days) 19 [8.3–42] 13.5 [8.3–32.3] 24.5 [17.5–42] 0.012
Duration of RRT (days) 15 [5–35] 10.5 [5–14.8] 18 [10–35] 0.006
In-hospitality mortality [n (%)] 0 (0) 0 (0) 0 (0) –
3-month mortality [n (%)] 4 (7.4) 0 (0) 4 (14) 0.11
eGFR at 3 months (ml/min/1.73 m2) 58 [49–92] 66 [68–92] 55 [49–77] 0.08
Table 2 Characteristics of the 54 analyzed patients at the first day (D0) of weaning of RRT
Weight’s variation means between admission and D0
p: differences between S+ and S− groups
SOFA Sequential Organ Failure Assessment
All patients (n = 54) S+ group (n = 26) S− group (n = 28) p
Non-renal SOFA 3 [1–6] 3 [1–5] 3.5 [1–7] 0.21
Mean arterial pressure (mmHg) 83 [77–93] 85 [77–93] 83 [76–94] 0.33
Mechanical ventilation [n (%)] 30 (56 %) 15 (57.7 %) 15 (53.6 %) 0.42
Weight’s variation (kg) −2.5 [− 9.3; −2.3] −6 [− 11; +1.5] −1.5 [− 4.9; +4] 0.12
Prior RRT length (days) 11 [5–18] 10.5 [5–14.8] 11 [6.3–24.5] 0.46
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than 75  %, received furosemide. We observed, however, 
that furosemide induced a significantly higher diuresis 
in the success group. Indeed, recent studies reported a 
significantly higher urine output in case of successful 
discontinuation of RRT even if diuretics were used [25, 
26]. Nevertheless, the usefulness of diuresis to guide RRT 
Table 3 Serum urea, serum creatinine, 24-h urine output, diuretics, urea and  creatinine clearance, 24-h urinary urea 
and creatinine, urea and creatinine generation rate, urinary urea/urea generation rate and urinary creatinine/creatinine 
generation rate ratios at the day (D0) of attempt of weaning and the following two days (D1, D2)
Italic values indicate significance of p value (p <0.05)
Results are displayed in median [interquartile range] if quantitative variable; and number and percentage if categorial variable
p: differences between S+ and S− groups
S urea serum urea, S creat serum creatinine, Furo furosemide, Diuretic RI diuretic response index, Cl clearance, UUr urinary urea, UCr urinary creatinine, UrGR urea 
generation rate, CrGR creatinine generation rate, Ur urea, Cr creatinine
D0 D1 D2
S+ S− p S+ S− p S+ S− p
S urea (mmol/l) 10 [7.6–13] 7.3 [6.2–12] 0.56 16 [12–24] 17 [14–21] 0.26 22 [15–37] 24 [20–27] 0.54
S creat (µmol/l) 105 [73–170] 83 [64–117] 0.36 177 [136–294] 158 [115–197] 0.15 227 [137–309] 218 [155–314] 0.65
24-h urinary output 
(l)
2.3 [1.5–3.5] 1.9 [1.0–2.5] 0.05 2.4 [1.8–3.7] 2.6 [1.7–3.3] 0.46 2.7 [2.1–3.4] 2.5 [1.7–3.3] 0.32
Use of furo [n (%)] 19 (73) 24 (86) 0.42 15 (59) 25 (89) 0.009 9 (35) 21 (75) 0.005
Dose of furo 
(mg/24 h)
470 [215–1000] 1000 [483–1000] 0.06 500 [125–970] 1000 [500–1000] 0.01 500 [250–1000] 1000 [500–1000] 0.01
Diuretic RI (ml/mg) 6 [2.9–15.4] 2.1 [1.1–6.4] 0.02 4.6 [3.6–26.4] 3.2 [1.9–4.3] 0.06 5.8 [2.5–8.2] 3.4 [2.6–5.8] 0.09
UrCl (ml/min) 15 [8–20] 6 [4–12] 0.008 12.5 [8–20] 7 [5–9] 0.001 13 [9–18] 6 [4–8] <0.001
CrCl (ml/min) 31 [15–41] 18 [7–26] 0.009 31 [18–40] 15 [8–21] 0.002 31 [16–42] 13 [6–21] <0.001
UUr (mmol/24 h) 187 [72–339] 85.9 [44–157] 0.031 357 [195–569] 147 [95–224] 0.002 592 [230–672] 236 [113–272] 0.002
UCr (mmol/24 h) 4.9 [2.5–6.4] 2.55 [0.7–3.9] 0.002 6.65 [5–8.8] 3.5 [1.6–4.4] <0.001 8.1 [6–9.5] 4.4 [2.2–5.2] <0.001
UrGR (µmol/min) 530 [331–722] 318 [254–442] 0.02 428 [257–681] 305 [232–393] 0.08
CrGR (µmol/min) 6.8 [5.8–9.9] 4.1 [2.9–5.2] <0.001 6.2 [4.8–7.8] 4 [3.4–4.9] 0.002
UUr/UrGR (%) 51 [36–61] 36 [24–48] 0.03 71 [62–84] 48 [31–60] <0.001
UCr/CrGR (%) 72 [53–85] 57 [40–67] 0.047 94 [77–100] 67 [44–82] <0.001
1-Specificity
0.00 0.25 0.50 0.75 1.00
D0 : AUC = 0.76 [0.62−0.89]
D1 : AUC = 0.86 [0.74 - 0.97]



























24-hour urinary output at D0a 24-hour urinary Creanineb
Fig. 2 Impact of 24-h urine output (a) and 24-h urinary creatinine at Days 0, 1 and 2 (b) on predictive ability of successful discontinuation of renal 
replacement therapy. The area under the receiver operating characteristic curve (AUC) is shown in each graph
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weaning is clearly reduced since diuretics often may be 
necessary to correct or avoid a fluid overload [33]. We 
sought then to determine predictive factors that would 
be independent of diuretics like urinary creatinine and 
urea. Urea and creatinine collected in urine during 
24-h were significantly higher at the day of attempt of 
RRT weaning and the following 2  days (with a gradual 
increase) in the success group. By multivariate analysis, 
24-h creatininuria was the most powerful predictor of 
success of weaning. A level ≥5.2 mmol/24 h had a Sp, Se, 
NPV and PPV of 75, 88, 82 and 84 %, respectively. Dif-
ferences of creatinine urinary level observed between the 
two groups should not be related to muscle mass, as they 
were independent of patient’s age and weight. Also, these 
differences may not be explained by differences of urea or 
creatinine generation rate since ratios of urinary levels to 
generation rates were significantly higher in the success 
group. Of note, clearance of creatinine (and urea) was 
significantly higher in the S+ group, as reported by Fröh-
lich et  al. [25]. In a recent study, Aniort and colleagues 
[32] sought also to identify predictive factors of intermit-
tent hemodialysis weaning by investigating retrospec-
tively 67 AKI patients. They found that daily urinary urea 
was the best weaning marker with an optimal threshold 
>1.35  mmol/kg/24  h (AUC 0.96, 95  % CI 0.93–0.99) as 
compared to 24-h urine output. In the contrary of our 
findings, they did not observe any differences in urinary 
creatinine between weaned and unweaned patients. 
However, almost 1/3 of their patients (22/67) have a base-
line GFR < 30 ml/mn and expectedly 26/67 patients did 
not recovered renal function. Our population included 
exclusively patients with a baseline GFR  ≥  60  ml/mn 
explaining, at least for a part, these discordant results.
RRT modalities (continuous or intermittent) may affect 
renal recovery and dialysis dependence, but their effects 
remain a matter of debate. A systematic review of the lit-
erature including mainly observational studies concluded 
that patients who received intermittent RRT had a signif-
icant increased risk of dialysis dependency as compared 
to those who received continuous RRT [34]. We observed 
indeed a higher proportion of continuous therapies with 
a higher weight decrease in the success group. However, 
differences were not significant and our RRT strategy was 
based on hemodynamic precluding any conclusions from 
our study. It is noteworthy that two recent studies failed 
to demonstrate any impact of RRT modalities on renal 
recovery [35, 36].
Patients who require RRT for AKI have a mortality 
exceeding 60  %, but most patients that recover func-
tion enough to be free from RRT survive to hospital dis-
charge [37]. In the study of BEST Kidney investigators 
[24], patients whose CRRT was successfully stopped had 
better outcome than those who needed to be re-treated 
(mortality: 28.5 vs 42.7  %, p  =  <0.0001, respectively). 
In our study, the patients who were weaned from RRT 
after a second or more attempt had a significantly higher 
length of RRT and of ICU stay as compared to patients 
successfully weaned. Moreover, we observed that 4/28 
patients of the failed group deceased 3 months later and 
none in the success group. Whether failure of discontinu-
ation of RRT is just a marker of severity of disease or is 
harmful by itself remains questioned [38].
This study has several limitations. First, it was a retro-
spective and bi-center cohort study. Second, the wean-
ing of RRT was not based on standardized criteria but 
decided by the attending physician who obviously fol-
lowed general rules. Third, daily urinary creatinine 
requires 24-h urine collection, a procedure routinely 
performed with accuracy in ICUs. The measurement 
of urinary creatinine in a shorter time period or as spot 
urine concentration would be more easily feasible but 
may induce less accuracy. Nevertheless, the use of uri-
nary creatinine as a marker of RRT cessation should be 
internally and externally validated to be used in routine 
Table 4 Performances of 24-h urine output, 24-h urinary creatinine and urea to predict the success of an attempt of renal 
replacement therapy weaning
PPV positive predictive value, NPV negative predictive value, CI confidence interval
Youden index [95 % CI] Sensitivity  % [95 % CI] Specificity  % [95 % CI] PPV  % [95 % CI] NPV  % [95 % CI]
D0 urinary output (ml/24 h) 2575 [1050–3075] 38.5 [19–58] 93 [82–100] 85 [61.5–100] 62 [55–71]
D0 urinary urea (mmol/24 h) 134 [56–322] 65 [48–83] 73 [58–88.5] 68 [53–84] 70 [58–84]
D0 urinary creatinine 
(mmol/24 h)
4.7 [0.85–5.1] 56.5 [35–74] 96 [88.5–100] 93 [78–100] 71 [62.5–81]
D1 urinary urea (mmol/24 h) 293 [196–363] 70 [50–90] 88 [76–100] 83 [67–100] 79 [68–92]
D1 urinary creatinine 
(mmol/24 h)
5.15 [3.01–6.3] 75 [55–90] 88 [72–100] 84 [68–100] 82 [70–93]
D2 urinary urea (mmol/24 h) 318 [292–591] 71 [52–90] 85 [69–96] 80 [64–94] 79 [68–92]
D2 urinary creatinine 
(mmol/24 h)
5.56 [4.67–6.57] 86 [71–100] 81 [65–96] 78 [65–94] 88 [75–100]
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practice. Last, we defined the attempt of weaning as a 
discontinuation of RRT during 72 h and estimated a suc-
cess if discontinuation lasted more than 15  days. Vari-
ous definitions have been used including an interruption 
of RRT during at least 5  days [23], but we thought that 
this duration may be too short regarding the severity of 
our patients. Also, considering RRT weaned after 7 days 
of interruption, as chosen by others [24, 25] has revealed 
insufficient. In the BEST Kidney cohort, for example, 15 
patients considered as RRT-free were re-treated by CRRT 
before discharged from the ICU [24]. Indeed, Wu et  al. 
[23] observed that an average of 10.1 ±  6.1  days lasted 
before re-dialysis if the attempt of weaning RRT failed.
Conclusions
In summary, the usefulness of 24-h urine output to pre-
dict the success of RRT weaning in AKI patients treated 
by diuretics may be significantly altered. Our study 
showed that 24-h urinary creatinine, in spite of diuretic 
use, is an independent and performing predictive fac-
tor of successful RRT weaning. A 24-h urinary creati-
nine ≥5.2  mmol indicates that RRT will be successfully 
stopped in 84  % of cases. Larger and prospective stud-
ies are needed to confirm our observations and to test a 
strategy of RRT weaning based on urine output, urinary 
creatinine and urea, and severity scores.
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